High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts

EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2018.01.031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Overexpression of ATP1B1 Predicts an Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia

Oncotarget
Oncology
2015English

High Expression of RUNX1 Is Associated With Poorer Outcomes in Cytogenetically Normal Acute Myeloid Leukemia

Oncotarget
Oncology
2016English

A Four-Gene LincRNA Expression Signature Predicts Risk in Multiple Cohorts of Acute Myeloid Leukemia Patients

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2017English

In Situ RHAMM Protein Expression in Acute Myeloid Leukemia Blasts Suggests Poor Overall Survival

Annals of Hematology
MedicineHematology
2011English

High Expression of Myocyte Enhancer Factor 2C Predicts Poor Prognosis for Adult Acute Myeloid Leukaemia With Normal Karyotype

British Journal of Haematology
Hematology
2020English

Human BDH2, an Anti-Apoptosis Factor, Is a Novel Poor Prognostic Factor for De Novo Cytogenetically Normal Acute Myeloid Leukemia

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2013English

High Expression of Dedicator of Cytokinesis 1 (DOCK1) Confers Poor Prognosis in Acute Myeloid Leukemia

Oncotarget
Oncology
2017English

High Expression of miR-25 Predicts Favorable Chemotherapy Outcome in Patients With Acute Myeloid Leukemia

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

BAALC Expression: A Suitable Marker for Prognostic Risk Stratification and Detection of Residual Disease in Cytogenetically Normal Acute Myeloid Leukemia

Blood Cancer Journal
OncologyHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy